Rein Therapeutics RNTX
NASDAQ RNTX
$0.80 -0.05 (-5.88%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rein Therapeutics (RNTX) Interest & Investment Income (2016 - 2017)

Updated

Rein Therapeutics (RNTX) recorded Interest & Investment Income of $167,000 in Q3 2017, compared with $10,000 a year earlier and up 475.9% from the prior quarter.

Analysis

Rein Therapeutics (RNTX) Interest & Investment Income (2016 - 2017) Analysis & Trends

On a TTM basis, Rein Therapeutics' Interest & Investment Income came in at $222,000 as of Sep 30, 2017.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Rein Therapeutics 53.67 Mn 53.67 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 167,000.00
Jun 30, 2017 29,000.00
Sep 30, 2016 10,000.00
Jun 30, 2016 16,000.00
API Access

Rein Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=RNTX&period=max&api_key=YOUR_API_KEY